Cardiff Oncology
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Cardiff Oncology's past years’ income statements indicate that its last revenue has increased compared to the previous period by 26% to $488,000. Profit margin reached -8492%. Total operating expenses were $45,900,000.
Profit Margin
| 2014 | 280K | -14.32M | -5116.07% |
|---|---|---|---|
| 2015 | 313K | -27.47M | -8776.68% |
| 2016 | 381K | -39.20M | -10289.76% |
| 2017 | 505K | -24.90M | -4932.08% |
| 2018 | 378K | -16.46M | -4354.76% |
| 2019 | 245K | -16.15M | -6592.65% |
| 2020 | 365.99K | -19.27M | -5267.85% |
| 2021 | 359K | -27.74M | -7727.58% |
| 2022 | 386K | -37.50M | -9716.58% |
| 2023 | 488K | -41.44M | -8492.01% |
CRDF Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 488K | 386K | 359K | 365.99K | 245K | 378K | 505K | 381K | 313K | 280K |
Cost of revenue | 0 | 200K | 500K | 11.23M | 11.16M | 597K | 1.81M | 1.73M | 629K | 15K |
Gross profit | 488K | 186K | -141K | -10.86M | -10.91M | -219K | -1.30M | -1.34M | -316K | 265K |
Operating exp. | ||||||||||
Research and development | 32.85M | 27.10M | 17.37M | 11.23M | 11.16M | 8.16M | 7.88M | 15.00M | 10.59M | 6.66M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 417 | 2.73M | 11.52M | 6.44M | 2.73M |
Total operating expenses | 45.9M | 40.28M | 29.21M | 19.45M | 16.92M | 16.17M | 22.11M | 38.00M | 24.95M | 15.21M |
Operating income | -45.41M | -39.90M | -28.85M | -19.08M | -16.67M | -17.05M | -25.59M | -40.14M | -25.27M | -14.94M |
Other income (expenses), net | 3.97M | 1.19M | 564K | -220.67K | 264K | -266K | 689.05K | 1.52M | -2.19M | 619.67K |
Income before tax | -41.44M | -38.70M | -28.29M | -19.30M | -16.41M | -16.46M | -24.90M | -39.20M | -27.47M | -14.32M |
Income tax expense | 0 | -1.19M | -549K | -26.72K | -262K | 617.64K | 716K | -296K | 1.81M | 608.18K |
Net income | -41.44M | -37.50M | -27.74M | -19.27M | -16.15M | -16.46M | -24.90M | -39.20M | -27.47M | -14.32M |
Earnings per share | ||||||||||
Basic EPS | -0.93 | -0.86 | -0.71 | -0.92 | -2.7 | -7.06 | -51.71 | -93.54 | -75.49 | -54.56 |
Diluted EPS | -0.93 | -0.86 | -0.71 | -0.92 | -2.7 | -7.06 | -51.71 | -93.22 | -74.77 | -54.08 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |